Rhett blood glucose monitoring system
Taiwan·Risk Class 2·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered May 24, 2019 – May 24, 2029Active- Analysis ID
- ee47f36040ee7a9671c96970dac60c3e
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
- Intended Use
- This product is specially designed for in vitro diagnostics (self-test and professional use) to measure fresh whole blood glucose obtained through the microvessels of the fingertips, palms or forearms, and is not suitable for newborns.
- Product Type (Level 1)
- A Clinical Chemistry and Clinical Toxicology;; I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical); I.4800 Surgical Hand Instruments for General Surgery;; A.1345 Glucose test system
- Import Information
- QMS/QSD;; 國產
- Registration Date
- May 24, 2019
- Expiry Date
- May 24, 2029
Top companies providing products similar to "Rhett blood glucose monitoring system"
Recently registered similar products
Access comprehensive regulatory information for Rhett blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ee47f36040ee7a9671c96970dac60c3e and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Daqing Factory of Huaguang Biotechnology Co., Ltd, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.